ReviewClinical medicine insights. Pediatrics2026
Preventing Medication Errors in Paediatrics: A Narrative Review.
Review in Clinical medicine insights. Pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paediatric medication errors remain a major and preventable cause of patient harm worldwide. Children are particularly vulnerable to medication-related adverse events because of weight-based dosing requirements, age-dependent pharmacokinetics, off-label medication use, communication limitations, and the need for complex drug preparation and administration processes. High-risk settings such as neonatal intensive care units, emergency departments, oncology services, and transitions of care are associated with particularly high rates of prescribing and administration errors. This narrative review examines the epidemiology, causes, and prevention of paediatric medication errors, with a focus on system-level contributors and evidence-based safety strategies. Common sources of error include dosing miscalculations, interruptions during medication administration, inadequate communication, insufficient paediatric-specific decision support, and caregiver-related challenges such as low health literacy and language barriers. The review highlights the role of technological interventions, including computerised physician order entry, clinical decision support systems, barcode medication administration, and smart infusion pumps in reducing prescribing and administration errors. Additional effective strategies include standardised dosing protocols, structured communication tools, pharmacist integration into multidisciplinary teams, independent double-checking processes, and family-centred education using teach-back methods and pictorial instructions. Although significant progress has been made in high-resource settings, important gaps remain in low- and middle-income countries where access to paediatric formulations, trained personnel, and electronic safety systems may be limited. Emerging technologies such as artificial intelligence-based dosing support may offer future benefits but also introduce ethical and governance challenges. Improving paediatric medication safety requires coordinated system-level approaches that combine technology, standardisation, workforce training, human-factors design, and active caregiver engagement to achieve sustained reductions in preventable harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.